Search Medical Condition
Please enter condition
Please choose location
Clear Trial Filters

Helicobacter Pylori Clinical Trials

A listing of Helicobacter Pylori medical research trials actively recruiting patient volunteers. Search for closest city to find more detailed information on a research study in your area.

RESULTS

Found (20) clinical trials

Local doctors are looking for people with H. Pylori for clinical research studies of an investigational medication. Must be receiving treatment for H. Pylori Must be at least 18 years old H. Pylori must be present for at least 3 months prior to first visit All patients will receive investigational ...

Phase N/A

The purpose of this study is to compare the effects of a study drug to an active comparator drug to find out which is better for treating H.pylori. Volunteers will receive compensations up to $75.00 -$100.00 per completed visit, for their overall participation in this study to cover their time ...

Phase N/A

The primary objective of this trial is to obtain stool samples from pre-therapy subjects already undergoing evaluation for an H. pylori infection by upper EGD (endoscopy) and gastric biopsy. Stipend: $53 for stool sample

Phase N/A

Food Effect on the Eradication Rate of H. Pylori With Triple Therapy With Esomeprazole

Phase IV, open, randomized, prospective study. - Length of experience: 180 days. - 06 visits. - Evaluation of the efficacy of differences regimens of administration.

Phase

Feasibility Study of Phototherapy System to Treat H Pylori

H pylori causes almost all peptic ulcers and many gastric cancers and is widely prevalent worldwide. Treatment by multiple antibiotics and proton pump inhibitors is effective but are compromised today by significant non compliance due to side effects and duration of required treatment. Also, the increase in antibiotic resistance coupled ...

Phase N/A

The Revolutions of Helicobacter Pylori Infection Bacterial Density and Histological Features After Antrectomy

The eradication of H pylori is known to reduce the recurrence rate of peptic ulcer and gastric inflammation. But it is still not clear about the prevalence of HP infection in patients after surgical interventions when the micro-environment had been changed. Since biliary enterogastric reflux is suggested to inhibit the ...

Phase N/A

Esomeprazole Moxifloxacin and Amoxicilin for Rescue Therapy of Helicobacter Pylori Infection

Successful H. pylori eradication therapy remains a challenge in medical practice. Currently, a PPI - based triple therapy containing clarithromycin, amoxicillin or nitroimidazole given for 7 days is the recommended first line treatment approach with an expected eradication success rate of approximately 80%. As second-line treatment option in case of ...

Phase

Helicobacter Pylori Empiric Treatment in Ulcer Bleeding

The goal of the study is to compare the effectiveness of empirical Helicobacter pylori treatment compared with treatment depending on diagnostic tests for Helicobacter pylori in patients with Upper gastrointestinal bleeding due to peptic ulcer. Main hypothesis is that empirical treatment will reduce the number of patients lost to follow-up ...

Phase

Tailored Treatment of H. Pylori Infection Based Polymorphisms of CYP2C19 and 23S rRNA of H. Pylori

Current treatment strategies for the eradication of H. pylori include a proton pump inhibitor (PPI) and one or two anti-bacterial agents, such as amoxicillin, clarithromycin, and metronidazole. PPIs, such as lansoprazole and omeprazole, are mainly metabolized in the liver by a genetically determined enzyme, S-mephenytoin 4'-hydroxylase (CYP2C19). Plasma concentrations of ...

Phase

Community-based Helicobacter Pylori Eradication

Despite the decline of global incidence, gastric cancer still affects public health substantially due to the considerable medical burden in the treatment of disease at the symptomatic stage. This fact has prompted clinicians to extend their attention from the multidisciplinary therapies to the design of preventive strategies. Gastric cancer development ...

Phase